Department of Health and Human Services

Treasury and HHS ConfirmationsHouse Appropriations Subcommittee on Departments of Labor, Health and Human Services, Education, and Related Agencies · 2026-04-16 · 119th Congress
The House Appropriations Subcommittee on Labor, HHS, Education convened this hearing to examine Secretary Robert F. Begins at 0:46:19
Transcript
Highlights

Title

FY2027 HHS budget hearing on vaccines, Medicaid, and rural health

Purpose

The House Appropriations Subcommittee on Labor, HHS, Education convened this hearing to examine Secretary Robert F. Kennedy Jr.'s Fiscal Year 2027 budget request for the Department of Health and Human Services, covering proposed cuts to CDC, NIH, and SAMHSA alongside rural health, vaccine policy, and grant-funding delays. Chairman Robert Aderholt (R-AL) and Ranking Member Laurel Lee (D-FL) opened with sharply differing views on the administration's record, before members questioned Kennedy on measles outbreaks, Medicaid, raw milk safety, glyphosate, mercury regulation, and fraud enforcement. Begins at0:46:19

Who spoke

Chairman Robert Aderholt (R-AL)0:46:19: Praised HHS's investigation into 13 states for Weldon Amendment violations0:46:19 and the $50 billion Rural Health Transformation Fund0:46:48; later pressed Kennedy on FDA's mifepristone black-box warning and adverse-event reporting gaps1:04:40 and on the Medicare hospital wage index's harm to rural, low-wage states1:07:44.

Ranking Member Laurel Lee (D-FL)0:48:34: Praised HHS's microplastics water-contaminant classification0:48:50; criticized the budget's proposed $16.5 billion (14%) cut to health agencies0:51:02, nearly 300 CDC staff on paid administrative leave for over a year0:53:12, the firing of CDC Director Susan Monarrez0:54:51, and OMB's 15-day funding schedules delaying grants0:56:53; said Congress will reject proposed cuts to NIH, CDC, SAMHSA, and LIHEAP0:57:20.

Secretary Robert F. Kennedy Jr., HHS0:59:05: Outlined "Make America Healthy Again" achievements including most-favored-nation drug pricing with 16 pharmaceutical companies0:59:59 and the $50 billion Rural Health Transformation Fund1:02:46; declined to discuss mifepristone due to Louisiana litigation1:05:39; said HHS employment fell from 82,000 to 62,000 and is rebuilding to 72,000 with 12,000 more hires1:24:36; defended holding up GAVI funding over thimerosal-containing vaccines2:12:37; said he fired all 17 members of the CDC vaccine advisory panel2:23:46.

Rep. Mark Pocan (D-WI)1:23:45: Questioned HHS staffing levels and reasons for cuts, disputing that reductions reflected employee competence1:23:451:26:15; asked about CDC morale and rehiring of recalled employees1:29:48.

Rep. Jake Ellzey (R-TX)1:31:20: Asked about anthrax countermeasures in the strategic stockpile1:31:20 and Chinese cybersecurity risks in medical devices1:32:15; shared a personal story about UK hospital care1:34:07.

A committee member (Spokane-area representative)1:34:44: Raised a prior unfulfilled promise for a follow-up call on the 988 line and LGBT funding1:35:05; pressed on whether HHS should timely expend appropriated funds1:36:02 and questioned Kennedy on glyphosate's carcinogenicity given his past statements1:37:15 and on animal welfare at Richland Farms beagle breeding facility supplying NIH-funded research1:39:35.

A committee member (Oklahoma representative)1:41:07: Praised NIH investment and hosting NIH Director Bhattacharya1:41:23; asked which NIH research areas would be cut or expanded1:43:04 and about China's growing lead in Phase 1 clinical trials1:45:09.

Rep. Lois Frankel (D-FL)1:47:24: Pressed Kennedy on withheld GAVI vaccine funding1:47:24 and delayed approval of Florida's state-directed Medicaid payment program, citing a potential $4.5 billion shortfall1:49:18; criticized proposed elimination of Title X family planning and fall-prevention programs1:50:40.

A committee member (following up on Chinese pharmaceutical/API issues)1:52:34: Asked about reshoring active pharmaceutical ingredient production1:53:01, BARDA contracting authority1:54:21, and rural provider cybersecurity1:55:38.

A committee member (asking about chronic disease data)1:58:26: Challenged Kennedy's sourcing for claims about "the sickest generation"1:58:26 and pressed on LIHEAP elimination despite prior commitments1:59:37, then on racial health disparities and elimination of the National Institute on Minority Health2:02:49.

Rep. Andrew Clyde (R-GA)2:05:03: Thanked Kennedy for expanded access to investigational drugs, citing a constituent's mitochondrial disease treatment2:05:34; asked about a new Title X "Protect Life" rule2:06:52 and Minnesota childcare fraud oversight2:08:36.

Rep. Buddy Carter (R-GA)2:10:48: Challenged Kennedy on his past mercury-pollution advocacy versus the administration's rollback of the Mercury and Air Toxics Standards2:11:13, leading to a contentious exchange in which Kennedy said the decision was EPA's, not his2:12:37.

A committee member (West Virginia representative)2:17:00: Praised coal-industry and NIOSH support2:18:48; asked about directing Child Care and Development Block Grant funds to kinship caregivers2:19:05 and fetal tissue research policy2:20:41.

Rep. Madeleine Dean (D-PA)2:21:10: Cited rising measles cases (285 in 2024, ~2,500 in 2025, 1,700+ in early 2026) and three deaths2:22:21; confirmed with Kennedy that the MMR vaccine is safe and effective2:22:53 but criticized declining vaccination rates and the firing of all 17 ACIP members2:23:46; questioned proposed SAMHSA and mental-health funding cuts2:25:57.

A committee member (discussing NIH indirect costs and Medicare Advantage)2:28:43: Praised scrutiny of sweetened-beverage SNAP spending2:29:03 and NIH indirect cost reforms2:30:24; raised Medicare Advantage "upcoding" concerns2:31:39 and asked about fraud, waste, and abuse crackdowns2:32:35.

Rep. Chuck Fleischmann (R-TN)2:34:56: Asked about Medicare Part D coverage of non-opioid pain medications2:35:23 and enforcement funding against illegal Chinese vape imports2:37:38.

Key moments

Lee said the budget proposes a $16.5 billion (14%) cut to health agencies, including 30% from CDC and $6 billion from NIH, and stated flatly "we are not going to do that"0:51:020:57:46.

Kennedy testified HHS employment dropped from 82,000 to 62,000 and is rebuilding to 72,000 with 12,000 new hires, framing prior cuts as a response to duplication (e.g., nine women's health offices, 27 HIV programs)1:24:361:27:36.

Kennedy confirmed HHS is withholding roughly $349 million in GAVI/childcare-related funds from Minnesota over alleged fraud, and separately holding up GAVI vaccine funding because it includes thimerosal-containing vaccines banned in Europe and the US2:09:242:12:37.

Sharp exchange: Rep. Carter repeatedly pressed Kennedy on the administration's rollback of mercury air-toxics rules given his career fighting mercury pollution; Kennedy repeatedly said it was an EPA decision he "doesn't know anything about," which Carter called "convenient amnesia"2:12:08.

Dean cited MMR vaccination coverage dropping to 92.5%, below the 95% outbreak-prevention threshold, alongside 1,700+ measles cases and three deaths in early 2026; Kennedy disputed a causal link to his removal of the ACIP panel2:23:222:24:35.

Kennedy said HHS has identified major Medicaid/hospice fraud, including 500 terminated hospices in California and a case where a hotel was filled with fake hospice patients billing $6,000/month2:33:582:34:27.

On raw milk, Kennedy said FDA does not regulate raw milk (states do) and declined to advise against drinking it despite a Raw Farm cheddar recall linked to E. coli that sickened nine and hospitalized three1:16:341:17:56.

Frankel said Florida faces a $4.5 billion annual federal funding shortfall because CMS has not approved its state-directed Medicaid payment program; Kennedy replied HHS meets weekly with Florida officials1:49:181:50:11.

Kennedy testified China now conducts nearly 40% of global clinical trials (up from 3%) and produced more licensed drugs than the US this year, citing $325 million in reshoring investment for pharmaceutical ingredient production1:46:011:53:07.

On glyphosate, a member noted Kennedy has called it a likely carcinogen; Kennedy confirmed he still believes that but said he had "grave reservations" about the administration's executive order expanding its use, calling it a national security necessity given Chinese control of the supply chain1:37:451:38:15.

Metadata

CommitteeHouse Appropriations Subcommittee on Departments of Labor, Health and Human Services, Education, and Related Agencies
Chamber / CongressHouse · 119th Congress
Date2026-04-16
TypeHearing
Witnesses
The Honorable Robert Kennedy Jr. — Secretary, U.S. Department of Health and Human Services
Videoyoutube
Transcript282 caption blocks · 19,332 words · 2:48:48 runtime
EventCongress.gov 119143